מיטוקסנטרון אבווה 2 מגמל

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

MITOXANTRONE AS HYDROCHLORIDE

Disponibil de la:

NOVARTIS ISRAEL LTD

Codul ATC:

L01DB07

Forma farmaceutică:

תרכיז להכנת תמיסה לאינפוזיה

Compoziție:

MITOXANTRONE AS HYDROCHLORIDE 2 MG/ML

Calea de administrare:

תוך-ורידי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA

Grupul Terapeutică:

MITOXANTRONE

Zonă Terapeutică:

MITOXANTRONE

Indicații terapeutice:

Treatment of advanced breast cancer, non-Hodgkin's lymphomas, acute non lymphocytic leukemia palliation of non resectable primary hepatocellular carcinoma. Mitoxantrone in combination with corticosterolds is indicated for inital chemotherapy in patients with pain due to advanced hormone-refractory prostate cancer. For reduction of neurologic disability and/or frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remmitting multiple sclerosis (patients whose neurologic status is significantly abnormal between relapses), for patients 18-55 years old.

Data de autorizare:

2023-12-31